Yucca Health review
A bundled online compounded-care offer
Yucca Health advertises compounded semaglutide with clinical review, medication, injection supplies, a patient portal and included shipping. It says there is no separate monthly membership charge. The product is compounded rather than branded Wegovy or Ozempic, and prescribing still depends on the clinician’s evaluation. A prominent result statistic or testimonial does not establish the outcome of an individual compounded prescription or guarantee that treatment will be appropriate.
The lowest equivalent requires annual payment
The semaglutide offer lists $89 on monthly billing, $450 for six months and $828 for twelve months. The $75 and $69 equivalents require the larger term payments. Compare the amount charged upfront and the selected renewal cadence, not just the smallest headline. Financing, when offered, is another agreement and should not be confused with the provider collecting a monthly program fee. Retain the checkout quote because promotional prices can change.
A price lock belongs to one enrollment
The offers policy ties locked pricing to the selected medication and billing cadence while enrollment remains active. Changing either creates a new plan at current pricing; canceling or allowing the plan to lapse ends the lock. Pausing can preserve it without charges under the published rules. Ask which arrangement applies before changing plans so an apparent saving does not accidentally end an existing rate. A lock does not establish permanent availability of every formulation.
The annual equivalent and a conditional commercial promise should be considered separately. Read our guide to prepaid plan risks. Cora Health review offers another longer-term commitment with a specific refund calculation for delivered supply.
Prescription issuance is the ordinary refund cutoff
The refund policy says payment is collected at checkout, before clinical review. If the clinician does not prescribe, it promises a full refund. Voluntary cancellation is fully refundable before a prescription is issued; afterward the order is generally final even if shipment has not occurred. These are payment-policy statements, not proof that the order can always be stopped before a clinician completes review. Check the order’s stage promptly if an address or purchase detail is wrong.
The six-month promise has strict conditions
The commercial promise applies to eligible injectable GLP-1 plans begun on or after September 18, 2026. It requires a logged starting weight, continuous paid treatment, following the prescribed plan, timely dose records and regular weight entries. Annual-plan customers must raise a claim before the six-month mark rather than relying on the general later claim window. It is a conditional refund commitment, not a medical assurance of weight loss. Read the full conditions before treating it as protection for every cancellation.
Renewals and shipment problems need prompt action
The refund policy asks patients to cancel at least seven days before renewal to avoid the next order; plans renew at the selected interval until paused or canceled. Multi-month early exits are reviewed case by case rather than guaranteed a simple unused-month refund. Damaged or missing packages have a 48-hour reporting window, and packaging should be retained. Ask the dispensing pharmacist about any temperature concern and confirm state and formulation availability before depending on broad national service language.
Compare other providers or explore semaglutide costs.